February 2016

home / publications / contemporary-radiation-oncology / february-2016
The Effect of Prostate MRI on Cancer Staging and Radiotherapy Treatment Recommendations

The Effect of Prostate MRI on Cancer Staging and Radiotherapy Treatment Recommendations

Jonathan D. Tward, MD, PhD;Breanne E. Terakedis, MD;Marta E. Heilbrun, MD;William T. Lowrance, MD;MPH, Kristine Kokeny, MD;Dennis C. Shrieve, MD, PhD
April 25th 2016
Article

Researchers evaluate the role of magnetic-resonance imaging in the clinical staging of prostate cancer in the definitive and salvage settings, and to identify changes in treatment recommendations.

Primary Radiation Therapy for Myeloid Sarcoma of the Porta Hepatis

Primary Radiation Therapy for Myeloid Sarcoma of the Porta Hepatis

Charlton A. Smith, MD;Miloš Miljković, MD;Ashkan Malayeri, MD;Jason Y. Cheng, PhD;Kevin A. Camphausen, MD;Dennis D. Hickstein, MD;Aradhana Kaushal, MD
April 9th 2016
Article

Treating myeloid sarcoma at the porta hepatis with 24 Gy over 12 fractions is a well-tolerated treatment that achieved a complete, durable response with minimal toxicity.

Prognostic Significance of Post-Treatment PET/CT Following Salvage Re-irradiation of Head and Neck Cancers

Prognostic Significance of Post-Treatment PET/CT Following Salvage Re-irradiation of Head and Neck Cancers

Tawee Tanvetyanon, MD, MPH;Tapan A. Padhya, MD;Judith C. McCaffrey, MD;Julie A. Kish, MD;Jimmy J. Caudell, MD, PhD;Andy Trotti, MD;Edward A. Eikman, MD
March 7th 2016
Article

Researchers explored the prognostic significance of PET/CT following re-irradiation in patients with head and neck cancer.

A Forum for Ideas, A Forum for Hope

A Forum for Ideas, A Forum for Hope

Mike Hennessy
February 21st 2016
Article

It was truly heartening to see Contemporary Radiation Oncology proudly represented by its Editor-in-Chief, Stephen E. Finkelstein, MD, at this year’s Fiesta Bowl.

An Outstanding Initiative of Honor and Remembrance

An Outstanding Initiative of Honor and Remembrance

Steven Eric Finkelstein, MD
February 17th 2016
Article

With more than 70,000 people in attendance, and potentially millions more watching on television, the 45th Annual Battlefrog Fiesta Bowl, held on Jan. 1, 2016, in Glendale, Arizona, filled the University of Phoenix Stadium with not only Ohio State and Notre Dame fans, but also with cancer survivors and people whose lives have been touched by cancer.